Connect your AI

United Therapeutics UTHR Stock-Based Comp

Stock-Based Comp at other companies

Tenet HealthcareTHC

$25M+19.0%

Johnson & JohnsonJNJ

$458M+11.7%

Merck & Co.MRK

$185M-5.1%

InsmedINSM

$45.75M+16.5%

Ethos Technologies, Inc. LIFE

$1.31M+11.0%

LQD

Liquidia CorporationLQDA

$9.22M+23.9%

Other financials

Income statement

Revenue$781.5M-1.6%

Gross profit$648.1M-7.7%

Operating income$325.8M-14.9%

Net income$274.9M-14.7%

EPS (diluted)$5.82-12.2%

Balance sheet

Cash & equivalents$1.3B-32.6%

Total debt$12.2M—

Total equity$5.9B-13.3%

Total assets$6.7B-13.3%

Cash flow

Operating cash flow$463.3M+0.5%

CapEx$100.8M+34.6%

Free cash flow$362.5M-6.2%

Valuation

Market cap$26.25B+90.4%

P/E20.4×+9.3×

P/S8.3×+3.8×

Profitability

Gross margin86.6%-2.4pp

Operating margin45.3%-1.6pp

Net margin40.6%+0.2pp

FCF margin32.1%-5.6pp

Returns & leverage

Return on equity20.3%+0.3pp

Debt / equity0×—

Current ratio4.8×-0.7×

Where this comes from

Reported directly by United Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensation.

The official record: United Therapeutics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about United Therapeutics's stock-based comp.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is United Therapeutics's stock-based comp?: United Therapeutics (UTHR) reported stock-based comp of $33.9M in Q1 2026.
How has United Therapeutics's stock-based comp changed year-over-year?: United Therapeutics's stock-based comp increased by 6.6% year-over-year, from $31.8M to $33.9M.
What is the long-term trend for United Therapeutics's stock-based comp?: Over 4 years (2021 to 2025), United Therapeutics's stock-based comp has grown at a 1.6% compound annual growth rate (CAGR), from $138.5M to $147.7M.
What does stock-based comp mean?: Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.